Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Smart Biopsy Market, by Application
1.4.2 North America Smart Biopsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Market Analysis
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Nov – 2016-May) Leading Players
Chapter 4. North America Smart Biopsy Market by Application
4.1 North America Breast cancer Market by Country
4.2 North America Skin cancer Market by Country
4.3 North America Liver cancer Market by Country
4.4 North America Prostate cancer Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Smart Biopsy Market by Country
5.1 USA Smart Biopsy Market
5.1.1 USA Smart Biopsy Market by Application
5.2 Canada Smart Biopsy Market
5.2.1 Canada Smart Biopsy Market by Application
5.3 Mexico Smart Biopsy Market
5.3.1 Mexico Smart Biopsy Market by Application
5.4 Rest of North America Smart Biopsy Market
5.4.1 Rest of North America Smart Biopsy Market by Application
Chapter 6. Company Profiles
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches:
6.1.5.2 Acquisition and Mergers:
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments:
6.2.1.1 Partnerships, Collaborations, and Agreements:
6.2.1.2 Acquisition and Mergers:
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments:
6.3.4.1 Acquisition and Mergers:
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Product Launches:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Expansions:
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Product Launches:
6.5.5.2 Acquisition and Mergers:
6.5.5.3 Expansions:
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.6.5.2 Acquisition and Mergers:
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Product Launches:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.7.5.3 Acquisition and Mergers:
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Product Launches:
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments:
6.10.5.1 Product Launches:
6.10.5.2 Acquisition and Mergers:
6.10.6 SWOT Analysis
Unique Offerings 